Dewdney R S, Soper C J
Mutat Res. 1984 Oct;129(1):119-27. doi: 10.1016/0027-5107(84)90130-1.
Tumour-promoting agents may bring about the completion of multi-step carcinogenesis by acting as enhancers of mutagenesis, recombinogens or clastogens. We report here that the classical mouse skin tumour promoter TPA, although non-mutagenic per se, can enhance the induction of OuaR CHO-K1 cell mutants by MNNG approximately 2-fold. This observation was made at a concentration approaching the compounds aqueous solubility limit which was non-cytotoxic. Mutagenesis enhancement was dependent on TPA being present throughout mutation expression and mutant selection. It was not accompanied by any modification of cell sensitivity to mutagen killing. In the same treatment protocol TPA did not enhance either EMS- or UV-induced mutagenesis. TPA exposure over 2 rounds of cell replication failed to produce an increase in the frequency of SCE in control or mutagen-treated CHO-K1 cultures. Likewise TPA exposure over 1 round of cell replication failed to produce an increase in the frequency of chromosomal aberrations. Apparently TPA is not a recombinogen or clastogen but in the right exposure regime is capable of acting to enhance mutagenesis by certain genotoxic agents, an action which may contribute to tumour promotion.
肿瘤促进剂可作为诱变增强剂、重组剂或断裂剂,促使多步骤致癌过程完成。我们在此报告,经典的小鼠皮肤肿瘤促进剂佛波酯(TPA),尽管其本身无致突变性,但可使N-甲基-N'-硝基-N-亚硝基胍(MNNG)诱导的哇巴因抗性(OuaR)中国仓鼠卵巢(CHO-K1)细胞突变体增加约2倍。这一观察结果是在接近该化合物水溶性极限且无细胞毒性的浓度下得出的。诱变增强依赖于TPA在整个突变表达和突变体选择过程中都存在。它并未伴随细胞对诱变杀伤敏感性的任何改变。在相同的处理方案中,TPA既未增强甲基磺酸乙酯(EMS)诱导的诱变,也未增强紫外线(UV)诱导的诱变。对CHO-K1细胞进行两轮复制期间暴露于TPA,并未使对照或经诱变剂处理的培养物中姐妹染色单体交换(SCE)频率增加。同样,对CHO-K1细胞进行一轮复制期间暴露于TPA,也未使染色体畸变频率增加。显然,TPA不是重组剂或断裂剂,但在适当的暴露条件下,能够增强某些遗传毒性剂的诱变作用,这一作用可能有助于肿瘤促进。